Mikah brought a number of drugs to Elite which helped drive some revenue so they didn't have to use as much toxic financing. I believe Isradipine and Naltrexone were two. NOTICE HE DOESNT MENTION THEM.
They have been huge drivers of our revenue especially Naltrexone which has been in shortage. Isradipine has been solid with not a lot of competition. Naltrexone may be the same.
He would rather have the company be bankrupt with LPC deals.
Half the guys are still covering short positions because LPC was toxic financing. Those shares were at I believe .04
This is like over 10 years ago. You can see when those IDs were created you see it all over the OTC.
Toxic financing draws flies that short companies out of existence. We still have some flies around.
Recent id but I will reply anyway: when we split from sungen, elite did not have enough money to buy the 50% adderall from them so Nasrat chipped in by way of mikah and saved the company. Elite is where it is today due to the mikah rescue. Some people do not like to pay debts. What can I say.
So it would have been a Chinese company - sungen, mikah or another company competing with elite that could have blocked us from producing adderall. I prefer mikah!!!
News 
Market Data 
Discover 
AI
